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A B S T R A C T
Polysialic acid (polySia) is a promising molecule for various medical applications (e.g., treatment of
inﬂammatory neurodegenerative diseases).
In this study a complete production process for human-identical a-(2,8)-linked polySia was developed
using a disposable bioreactor for cultivation of Escherichia coli K1 and single-use membrane adsorbers for
downstream processing (DSP). The cultivation process was optimized to minimize complex media
components and a maturation process after cultivation was established. The maturation led to further
product release from the cell surface into the supernatant. Afterwards DSP was established using sodium
hydroxide treatment combined with anion exchange membrane adsorbers for endotoxin and DNA
depletion.
After downstream processing the ﬁnal product had neither detectable protein nor DNA contamination.
Endotoxin content was below 3 EU mg1. Investigation of the maximal chain length showed no effect of
the harsh sodium hydroxide treatment during DSP on the stability of the polySia. Maximal chain length
was 98 degree of polymerization.
© 2018 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Polysialic acid (polySia) is a polysaccharide consisting of
a-(2,8)- and/or a-(2,9)-linked N-acetylneuraminic acid mono-
mers. PolySia is a promising molecule for application in tissue
engineering [1], vaccine development and cancer immunotherapy
[2–6]. Furthermore, a-(2,8)-polySia is a potential drug for the
treatment of inﬂammatory neurodegenerative diseases (e.g., age-
related macular degeneration) [7,8]. Production of polySia is
commonly realized as endogenous product of cultivated bacteria
(e.g., Escherichia coli K1 or Neisseria meningitidis B) [2,9–12]. The
polySia of the Escherichia coli K1 capsule consists of a-(2,8)-linked
N-acetylneuraminic acid and is identical to the polySia found in the
human body [13,14]. Recently a process was developed using a
disposable bag reactor for the cultivation instead of a conventional
stirred tank reactor often used for bacteria cultivation [11]. Single-
use systems have become widely accepted for the production of
biological agents for pharmaceuticals and medical biotechnologi-
cal applications [15].* Corresponding author at: Institute of Technical Chemistry, Leibniz University Hann
E-mail address: beutel@iftc.uni-hannover.de (S. Beutel).
https://doi.org/10.1016/j.btre.2018.02.001
2215-017X/© 2018 The Authors. Published by Elsevier B.V. This is an open access article unThe main advantages of single-use systems are reduced risks for
cross-contamination, high ﬂexibility, less complexity of the
production plant as sterilization and cleaning steps are reduced
as well as easier production in terms of regulatory requirements
due to omitted validation and documentation of those sterilization
and cleaning steps [16]. Nevertheless, the presence of leachables
originating from the plastic material is undesired within the
production process [16,17]. Furthermore, costs for the disposable
parts constantly occur [16,17], but investment costs are low.
For high quality products not only the production process has to
be in accordance to the regulatory requirements of GMP-
production (good manufacturing practice), also product purity
has to be strictly controlled, especially for products intended for
medical application. Therefore downstream processing (DSP) is
another important part of a biotechnological production process.
All steps which are necessary to purify the target product require a
large part of the overall production costs [18,19].
Reported puriﬁcation processes for polySia are based on
precipitation and/or adsorption methods [10,12]. Process-relatedover, Callinstr. 5, 30167, Hannover, Germany.
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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components of USP and DSP) as well as product-related impurities
(e.g., precursors and degradation products) can affect the product
properties. Therefore, different chromatographic methods can be
exploited to obtain the desired product purity. Molecules can be
separated based on different properties, such as afﬁnity (afﬁnity
chromatography), size (SEC = size exclusion chromatography),
hydrophobicity (HIC = hydrophobic interaction chromatography)
and charge (IEX = ion exchange chromatography). Especially, the
depletion of impurities, such as endotoxins, is challenging.
Endotoxins are negatively charged, complex lipopolysacchar-
ides (LPS) and part of the outer membrane of gram-negative
bacteria. Even small quantities have a high impact on health of
human beings. Endotoxins cause inﬂammatory response at
concentrations greater than 1 ng kg1 h1, based on the body
weight [20–22]. The Food and Drug Administration (FDA)
regulations deﬁne the maximum allowable endotoxin exposure
at 5 EU kg1 h1 (EU = endotoxin units). For the removal of
endotoxins different techniques are reported: chromatography
(such as ion exchange chromatography [23,24], or resins based on
immobilized polyethyleneimine [25]), ultraﬁltration [26], afﬁnity
adsorbents [27–31], Triton X-114 phase separation [32,33],
modiﬁed membranes [34] and membrane adsorbers [35]. Mem-
brane adsorbers have several advantages compared to classical
resin technology, e.g., convective material transport, higher ﬂow
rates, easy scale-up and single use. For depyrogenation sodium
hydroxide treatment is widely used [36,37].
This study is focused on the development and optimization of a
complete production process for long-chain and highly pure
polySia. Single-use elements are implemented in the overall
process. The downstream processing is improved by a sodium
hydroxide treatment and anion exchange membrane adsorbers to
obtain highly pure polySia fractions. The produced polySia is
analyzed after the production process regarding protein, DNA,
endotoxin content and maximal chain length. The production
process is compared to the already reported established processes
for polySia production.
2. Materials and methods
2.1. Bacterial strains and stock cultures
As previously reported E. coli B2032/82 serotype K1 was used
for the experiments [10–12]. The wild type strain E. coli B2032/82
serotype K1 is an original clinical isolate [10]. Stock cultures were
prepared as previously reported [11].
2.2. Chemicals and growth media
Bulk chemicals were purchased from Sigma–Aldrich (Tauf-
kirchen, Germany). Oxygen was purchased from Linde (Pullach,
Germany). Deionized water was prepared with Arium1 (Sartorius
Stedim Biotech, Göttingen, Germany). For the preculture used for
bioreactor inoculation and the main bioreactor cultivation a
deﬁned salt medium was used. The composition was reported
previously [12].
2.3. Cultivation of E. coli K1
2.3.1. Shake ﬂask cultivation and preculture
First stock cultures were transferred in complex medium and
cultivated for 8 h on a rotary shaker at 37 C and 130 rpm. Complex
medium composition was reported earlier [11] and complex
medium was only used for the ﬁrst shake ﬂask cultivation to
inoculate the preculture for the main bioreactor cultivation.
Afterwards 20 mL of this culture (shake ﬂask cultivation incomplex medium) was transferred into 100 mL deﬁned salt
medium and incubated for 10–12 h at the mentioned conditions.
These cells were used as inoculum for the bioreactor cultivation.
For inoculation 300 mL preculture was used (3% v v1 of total
cultivation volume).
2.3.2. Disposable bag reactor
For the main bioreactor cultivation a disposable bag reactor
with wave-induced mixing and a total volume of 20 L (maximal
working volume: 10 L) was used (BIOSTAT1CultiBag RM 20 optical,
Sartorius Stedim Biotech, Göttingen, Germany). Cultivation con-
ditions were used as previously reported [11]. For effective and
efﬁcient fermentation control online parameters were analyzed
and after ofﬂine sampling analysis are made describing the actual
culture conditions [38].
2.3.3. Ofﬂine sampling
Ofﬂine samples were analyzed during the cultivation. Measure-
ments of optical density, cell dry weight and glucose concentration
were performed as previously reported [11].
2.4. Downstream process
2.4.1. Maturation process and cell separation
For maturation the produced cells were stored for 17 h at 8 C.
After maturation process cells were separated by continuous
centrifugation as previously reported [11].
2.4.2. Product concentration via cross-ﬂow ultraﬁltration
After cell separation the supernatant was concentrated to a ﬁnal
volume of 250 mL with a cross-ﬂow device (Sartoﬂow1 Smart,
Sartorius Stedim Biotech, Göttingen, Germany). The ﬁlter cassette
had a molecular weight cut-off (MWCO) of 10 kDa (Hydrosart1,
Sartorius Stedim Biotech, Göttingen, Germany). The inlet pressure
towards the ﬁlter cassette was regulated to maximal 2 bar by
controlling the ﬂow rate of the pump.
2.4.3. Precipitation with ethanol
Precipitation of the retentate after cross-ﬂow ﬁltration with
ethanol was performed in three subsequent steps. For precipitation
80% v v1 ethanol was used. The precipitate was spun down at
4816 g and 4 C for 15 min after the ﬁrst, for 20 min after the second
and for 60 min after the third precipitation step (Multifuge X3 FR,
Thermo Scientiﬁc, Waltham, USA). The pellet was dissolved in
water after each precipitation step.
2.4.4. Puriﬁcation with clay minerals
Calcium bentonite EX M 1753 (experimental product name
1753, CAS registry number: 1302-78-9, Clariant, Moosburg,
Germany) was used for protein adsorption as previously reported
[11].
2.4.5. Sodium hydroxide treatment
After puriﬁcation with calcium bentonite the sample was
treated with sodium hydroxide. The pH was set to pH 13 with 2 M
NaOH and the solution was mixed at room temperature for 18 h.
Afterwards the pH was adjusted to pH 7.4 with 1 M HCl, 10 mM
triethanolamine was added and the solution was ﬁltered with a
0.2 mm bottle top sterile ﬁlter (Sartolab1, Sartorius Stedim Biotech,
Göttingen, Germany).
2.4.6. Puriﬁcation of polySia with anion exchange membrane
adsorbers
2.4.6.1. Evaluation of membrane adsorbers in an FPLC system. The
puriﬁcation process using anion exchange membrane adsorbers
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Chicago, USA) with Sartobind1 Q 75 (membrane area: 75 cm2,
column volume (CV): 2.1 mL). The system control software
UnicornTM 6.4 was used. The membrane adsorber was
equilibrated with 5 CV running buffer (100 mM triethanolamine,
pH 7.4). Afterwards, the pretreated sample was loaded onto the
membrane adsorber, followed by a washing step with 5 CV running
buffer. A linear gradient elution was performed over 20 CV with
elution buffer (1 M NaCl). The column was re-equilibrated with 5
CV running buffer before the next run. The ﬂow rate was set to
15 mL min1 during the chromatographic run. During the whole
process fractions were collected for further analysis.
2.4.6.2. Upscale of membrane adsorber technique for polySia
puriﬁcation. The upscale of the downstream processing was
carried out with Sartobind1 Q 75 mL (membrane area: 2700 cm2,
CV: 75 mL) (Sartorius Stedim Biotech, Göttingen, Germany). The
chromatographic protocol was described in the previous section.
Only the sample elution was changed to an isocratic elution of 75%
elution buffer (5 CV). The ﬂow rate was set to 100 mL min1 during
the chromatographic run.
Detailed information about the membrane adsorber, sample
volume and composition are described in the “Results and
discussion” chapter.
2.4.7. Dialysis
The eluate was splitted into 250 mL fractions and each fraction
was dialyzed against 5 L deionized water with 0.02 M NaCl for 24 h
at 8 C and afterwards twice against 5 L deionized water for 24 h at
8 C for each (every time pH 9, set with NaOH) using a Visking
dialysis membrane (Carl Roth GmbH & Co. KG, Karlsruhe, Germany)
with a MWCO of 14 kDa.
2.4.8. Lyophilization
Freeze drying was performed as previously reported [11].
2.5. Analysis
2.5.1. Standard analysis
During cultivation, downstream processing and for the ﬁnal
characterization of the product several analysis were performed.
The polySia concentration was measured with a modiﬁed
thiobarbituric acid assay, protein concentration was determinedFig. 1. Process scheme.
The overall production process of polysialic acid is shown. First cultivation is perform
followed by downstream processing and characterization of the ﬁnal product.by the Bradford method, DNA concentration by UV–vis absorption
(NanoDrop 2000, Thermo Scientiﬁc, Waltham, USA), endotoxin
concentration with Endosafe-PTSTM system (Endosafe-PTSTM,
Charles River Laboratories, Boston, USA) and the chain length
characterization with DMB-HPLC analysis (DMB = 1,2-diamino-
4,5-methylenedioxybenzene). Cell disruption was performed with
ultrasonic treatment. All methods were performed as previously
reported [11].
2.5.2. Polymerase chain reaction and gel electrophoresis for DNA
analysis
For further DNA analysis polymerase chain reaction (PCR) and
gel electrophoresis were performed. PCR reactions were conducted
as follows: 10 mL 5 Green GoTaq1 Reaction Buffer (Promega,
Fitchburg, USA), 4 mL dNTP mix (2 mM each) (Thermo Fisher
Scientiﬁc, Waltham, USA), 2 mL primer mix (E. coli forward: 50-
GAGCGCAACCCTTATCCT-3‘, E. coli reverse: 50-GGTTCCCCTACGGT-
TAC-30) (MWG-Biotech AG, Ebersberg, Germany), 1 mL template
and 0.25 mL GoTaq1 G2 DNA Polymerase (Promega, Fitchburg,
USA) in a total volume of 50 mL (add H2O). Ampliﬁcation was
performed for 40 cycles after initial denaturation at 95 C for 5 min
as follows: 95 C for 30 s, 51 C for 30 s, and 72 C for 30 s. After
5 min at 72 C PCR was stopped and the samples were stored at
4 C.
For gel electrophoresis 1.5% w v1 agarose gels were prepared
and 0.005% v v1 HDGreenTM (Intas Science Imaging Instruments
GmbH, Göttingen. Germany) was added for staining. Gel electro-
phoresis was performed for 1 h at 110 V.
3. Results and discussion
In the following the results of the cultivation process,
downstream processing and product characterization are shown.
The polySia production process is shown in Fig. 1.
3.1. Cultivation process in a disposable bag reactor
In contrast to a previously reported cultivation process [11], the
preculture was also prepared in a deﬁned media as used in the
cultivation process. This step was implemented to avoid contami-
nation of deﬁned medium with complex compounds (e.g., yeast
extract) and other byproducts of the preculture.ed in a disposable bag reactor. After cultivation maturation process is carried out,
Fig. 2. Evaluation of the membrane adsorber in the FPLC system.
The membrane adsorbers Sartobind1 Q 75 (membrane area: 75 cm2, CV: 2.1 mL)
were used for evaluation. Fractions of sample application (1.A.1–1.A.3) showed
increasing content of polySia (grey bars) as maximal dynamic binding capacity of
the membrane adsorber was reached. After sample application and washing NaCl
content (B) (line: dash) was increased as also conductivity increases (line: dot).
PolySia was mainly eluted between 0.1 M and 0.75 M NaCl. UV-signal (line: solid)
showed only low intensity as protein content was reduced heavily before
membrane adsorber evaluation.
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(0.8) g L1, a polySia concentration in the supernatant of 300.9
(19.8) mg L1 and a protein concentration in the supernatant of
108.8 (41.5) mg L1 was reached. Total polySia concentration
after cell disruption was 560.5 (56.9) mg L1. Thus, 54 (7)% of
the polySia was released during cultivation. In total three
cultivations were performed. Data are presented as mean 
standard deviation.
The results of the cultivation process are within the range of the
conventional process [11]. Nevertheless, polySia concentration was
increased by 23% and protein concentration was decreased by 17%
in the supernatant.
3.2. Maturation process after cultivation
The disposable bag reactor provides the opportunity for an easy
and sterile storage after cultivation. The culture broth can be stored
directly in the reactor containment (bag) and transported to the
desired storage/maturation place. In this case the maturation
process was performed at 8 C for 17 h. Whereas in the established
process the cells were directly separated after cultivation to avoid
cell lysis and host cell protein release into the supernatant [11], the
maturation process was implemented to release still bound polySia
from the cells into the supernatant and make it available for further
downstream processing. Furthermore, the cultivation process can
be decoupled from the downstream processing by storage of the
culture broth.
The ﬁnal polySia concentration after maturation process was
332.6 (36.3) mg L1 and protein concentration in the supernatant
was 191.6 (84.8) mg L1, which is an increase in product
concentration by about 10% but also an increase in protein
impurity of about 75%. The total polySia concentration after cell
disruption is constant. Thus, polySia was further released from the
cells into the supernatant, but not newly produced, during storage.
3.3. Downstream processing of the produced polySia
Afterwards, downstream processing was performed to provide
suitable product purity for the desired application. Critical
parameters of the product are protein and DNA concentration as
well as endotoxin concentration. In previous studies downstream
processing based on clay minerals and/or anion exchange
membrane adsorbers was performed [11,12]. The processes
focused mainly on the removal of protein contamination.
Nevertheless, due to use of membrane adsorber treatment also
endotoxin was reduced to 14 EU mg1 [12].
In the following a new downstream process was established,
focusing, as well on the removal of protein contamination using
the established methods of ethanol precipitation and clay minerals
[11,12], as on the removal of endotoxin contamination using
sodium hydroxide treatment and anion exchange membrane
adsorbers.
3.3.1. Cell separation, product concentration and protein removal
Cell separation after maturation was performed using continu-
ous centrifugation as previously reported [11]. The composition
(protein to polySia) of the supernatant after maturation process
and cell separation had a ratio of approximately 0.6 gpro-
tein gpolySia
1.
The 10 L supernatant were concentrated 40-fold to 250 mL
using cross-ﬂow ultraﬁltration. For cross-ﬂow ultraﬁltration a
Sartoﬂow1 Smart device (Sartorius Stedim Biotech) with a ﬁlter
cassette with MWCO of 10 kDa was used. The system provides
ﬂexibility due to exchangeable tubes and feed pump and is
accepted in cGMP environments. The concentrate (volume:
250 mL) had a composition of 6417 (779) mg L1 polySia and2539 (783) mg L1 protein (ratio approximately 0.4 gpro-
tein gpolySia
1). During concentration with ultraﬁltration nearly
50% of the produced polySia got lost. Product was lost in the
permeate (polySia with chain length under 35 degree of polymeri-
zation, DP [12]), as well as in the dead volume of the system and/or
binding to the ﬁlter membrane.
Removal of protein was based on a previously reported process
[11]. In comparison to the reported process ethanol precipitation
was improved. Due to increased centrifugation time instead of
altering ethanol concentration from 80% v v1 up to 90% v v1
ethanol [11] polySia loss was minimized to less than 10%. After
ethanol precipitation, the ratio was approximately 0.3 gpro-
tein gpolySia
1. Then a subsequent clay mineral adsorption was
performed as previously reported [11], yielding polySia with
protein impurity left below 0.05 gprotein gpolySia1.
The material with low protein contamination was used for
further downstream processing to reduce the endotoxin and DNA
content of the product. Previous studies showed, that after DSP
based on the mentioned treatment with ethanol and clay minerals
endotoxin concentration was still above 1000 EU mg1 and DNA
was 5.5 (0.5) mgDNA gpolySia1 [11].
3.3.2. Sodium hydroxide treatment
Sodium hydroxide is commonly used for endotoxin removal in
puriﬁcation processes for products produced in E. coli as Poly(3-
Hydroxybutyrate) or polySia [36,37]. Treatment with sodium
hydroxide at pH 13 showed no loss of polySia. The sample was
neutralized to pH 7.4 after the treatment and further puriﬁed with
anion exchange membrane adsorbers. As reference a sample
without sodium hydroxide treatment was further puriﬁed to
compare the obtained materials in terms of endotoxin concentra-
tion and chain length. Endotoxin was effectively removed with this
method and maximal chain length showed no signiﬁcant
difference between the materials treated with sodium hydroxide
and the control. Detailed information on the product purity and the
chain length are shown in section “Purity”.
Fig. 4. Agarose gel electrophoresis for E. coli DNA analytic after polymerase chain
reaction.
The ﬁnal polySia product (d) and the negative control (water, a) show no signal for
ampliﬁed DNA. The positive control (E. coli K12 DNA, c), the supernatant of the
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3.3.3.1. Evaluation of membrane adsorbers in FPLC
system. Membrane adsorbers were tested in an FPLC system
using Sartobind1 Q 75 (membrane area: 75 cm2, CV: 2.1 mL).
PolySia binding capacity and elution proﬁle were evaluated. The
chromatogram comprising elution gradient, UV-signal,
conductivity and polySia concentration in the collected fractions
is shown in Fig. 2. The membrane adsorber was loaded with high
amounts of long-chain polySia (maximal chain length 98 DP). The
maximal dynamic binding capacity was determined by the amount
of adsorbed polySia after the binding capacity was exceeded and
the adsorber was washed. The maximal dynamic binding capacity
of the Q membrane adsorber was 0.25 (0.03) mg cm2.
After the loading step the column was washed with loading
buffer to remove loosely bound polySia and other undesired
components (e.g., endotoxin fragments). Afterwards polySia
elution was performed with a linear salt gradient. Elution of
polySia occurred between 0.1 M and 0.75 M NaCl. Eventually the
membrane adsorber was washed with 1 M NaCl. As control polySia
without previous sodium hydroxide treatment was used. The
control showed similar binding and elution behavior. Comparison
of endotoxin content and product stability of the material and the
control is shown in section “Purity”.
3.3.3.2. Upscale of the puriﬁcation process using membrane
adsorbers. After evaluation shown before an upscale of the
puriﬁcation process using Sartobind1 Q 75 mL (membrane area:
2700 cm2, CV: 75 mL) was performed. Instead of a NaCl gradient as
reported above isocratic elution with 0.75 M NaCl was performed,
because further increase of NaCl concentration showed no further
polySia elution. The membrane adsorber was loaded after
equilibration with maximal 600 mg polySia, due to the capacity
measured during evaluation. Several loading and elution cycles
were performed to avoid polySia loss due to limitation of
membrane adsorber capacity. After this membrane puriﬁcation
step almost no polySia was lost.Fig. 3. Downstream processing.
Protein (grey bars) was reduced efﬁciently during downstream processing. After
DSP no protein and DNA was detectable in the ﬁnal product after lyophilization, due
to implementation of NaOH treatment and membrane adsorbers. Endotoxin of the
ﬁnal product was below 3 EU mg1. The recovery yield of polySia (white bars) after
DSP was 29 (7)%.3.3.4. Dialysis and freeze drying
After puriﬁcation with membrane adsorbers, dialysis and freeze
drying steps of the product were performed as previously reported
[11] to produce a tailor made product. The shown puriﬁcation
process had a recovery yield of 29 (7)%, as shown in Fig. 3.
Compared to the easy to handle and time-saving previously
reported process which focused only on the removal of protein
[11], recovery yield was improved by 3% and endotoxin and DNA
content was reduced heavily (data is shown in section “Purity”).
3.4. Analysis of the ﬁnal product
3.4.1. Purity
Protein content of the produced polySia was below detection
limit of the used method (Bradford method). Thus, protein content
is comparable to the established puriﬁcation methods [10–12]. The
aim of the newly developed puriﬁcation process implementing
sodium hydroxide treatment and membrane adsorbers in the
overall process was the reduction of the remaining DNA and
endotoxin content.
Content of DNA in the ﬁnal product was below detection limit
measured by absorbance measurement at 260 nm and gelFig. 5. Characterization of maximal polySia chain length.
The maximal chain length of the ﬁnal polySia product was 98 DP as measured by
DMB-HPLC analysis. PolySia was labelled with DMB (1,2-diamino-4,5-methylene-
dioxybenzene) and the different chain lengths can be detected with a detection
threshold of 1.4 fmol [40]. Due to the partial hydrolysis of polySia during
derivatization with DMB no quantitative analysis of the polySia chain length
distribution was possible.
cultivation (e) and the supernatant after cell disruption (f) show DNA contamina-
tion. The detected E. coli K12 DNA has a size of 400 bp as estimated by the marker (
GeneRulerTM 100 bp Plus DNA Ladder, Thermo Scientiﬁc, b), which is in alignment
with the expected size of 418 bp.
Table 1
Characteristics of the ﬁnal product.
Characteristic Content Analytical method
Protein Not detectable Bradford method
Absorbance measurement at 260 nm
DNA Not detectable Gel electrophoresis after polymerase chain reaction
Endotoxin < 3EU mg1 Based on LAL-test
Maximum chain length 98 DP DMB-HPLC analysis
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Thus, by implementation of sodium hydroxide treatment followed
by anion exchange membrane adsorbers DNA was effectively
reduced.
An important characteristic especially for products intended for
medical application is the endotoxin content. In the previously
reported process endotoxin content of the produced material was
above 1000 EU mg1 [11]. Using a membrane adsorber based
puriﬁcation method endotoxin content was reduced to 14 EU mg1
[12]. With the downstream processing developed in this study a
ﬁnal product with endotoxin content less than 3 EU mg1 was
produced. A control using only membrane adsorbers without prior
sodium hydroxide treatment showed an endotoxin concentration
of 641 (139) EU mg1.
The overall reduction of the endotoxin content can be expressed
with a log reduction value (LRV), which is the logarithmic quotient
(log10) of endotoxin concentration of the supernatant after
cultivation divided by the endotoxin concentration after down-
stream processing. The endotoxin concentration after cultivation
was >20*106 EU mgpolySia1.
LRV ¼ logcendotoxin start
cendotoxin end
The LRV with sodium hydroxide treatment is 7.0 and without
sodium hydroxide treatment 4.5. Thus, sodium hydroxide
treatment is suitable to gain a product with low endotoxin
contamination.
3.4.2. Chain length of the produced polySia
An important characteristic of the produced polySia is the chain
length. Due to the optimized downstream processing using harsh
treatment with sodium hydroxide stability of the polySia could be
affected. In the following, the maximal chain length of the
produced polySia was measured using DMB-HPLC analysis and
compared to the control without sodium hydroxide treatment and
to the already established process for polySia production in a
disposable bag reactor [11].
Maximal chain length of the produced polySia was 98 DP as
shown in Fig. 5. The maximal chain length is comparable to the
previously established processes [10–12]. The control without
sodium hydroxide treatment showed no difference, neither in
maximal chain length, nor in ﬂuorescence intensity of the single
peaks in the chromatogram. Thus, the sodium hydroxide treatment
had no inﬂuence on the stability of the produced polySia.
All characteristics of the ﬁnal product are shown in Table 1.
4. Conclusions
This study describes a complete production process based on
single-use elements for production of polySia beginning with the
cultivation of E. coli K1 in a disposable bag reactor and using
downstream processing with sodium hydroxide treatment and
disposable anion exchange membrane adsorbers to obtain a ﬁnal
product with high purity. Both, cultivation in a disposable bag
reactor and DSP using membrane adsorbers are well accepted inGMP-production. Further beneﬁts of the used elements are the
easy scale up to larger production capacities and ﬂexibility.
The cultivation was optimized using deﬁned preculture
medium. Thus, only negligible amounts of complex media
components (e.g., yeast extract) were transferred into the main
bioreactor during inoculation. For quality assurance deﬁned media
are important during production processes [39]. Furthermore, due
to the established maturation process higher product concentra-
tion of polySia in the supernatant was obtained.
After maturation cells were separated and DSP was developed
based on the established protocol using ethanol precipitation and
clay minerals [11], but also sodium hydroxide treatment and
membrane adsorbers were implementing for further endotoxin
and DNA depletion. With this DSP polySia with high purity was
obtained, suitable for further applications (e.g., tissue engineer-
ing). Maximal chain length of polySia was comparable to the
previously established puriﬁcation processes [10–12] and was not
affected by sodium hydroxide treatment.
Thus, the shown production process focusing on single-use
elements well accepted in GMP-production is suitable for polySia
production with low endotoxin content and protein and DNA
contamination below the detection limits of the applied assay
systems.
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